Anthony D’Ippolito

6.5k citations

20 papers · 2.6k indexed · 2 hit papers · h-index 10

Molecular Biology top 5%
Genetics top 5%
Plant Science top 10%
Cancer Research top 10%
Aging top 1%

Co-authors: Timothy E. Reddy Charles A. Gersbach Gregory E. Crawford Pratiksha I. Thakore Christopher M. Vockley Isaac B. Hilton Lingyun Song Alexias Safi
Topics: Advanced Breast Cancer Therapies (5 papers)Genomics and Chromatin Dynamics (5 papers)CRISPR and Genetic Engineering (4 papers)
Cited by: Aging Business and International Management Molecular Biology
Journals: Cell Journal of Biological Chemistry Nature Communications
Partner nations: United States Canada

In The Last Decade

Anthony D’Ippolito

15 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers

2015 1.3k citations Isaac B. Hilton, Anthony D’Ippolito et al. Nature Biotechnology profile →
Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

2015 690 citations Pratiksha I. Thakore, Anthony D’Ippolito et al. Nature Methods profile →

Peers

Countries citing papers authored by Anthony D’Ippolito

Since Specialization

Citations

This map shows the geographic impact of Anthony D’Ippolito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony D’Ippolito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony D’Ippolito more than expected).

Fields of papers citing papers by Anthony D’Ippolito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony D’Ippolito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony D’Ippolito. The network helps show where Anthony D’Ippolito may publish in the future.

Co-authorship network of co-authors of Anthony D’Ippolito

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony D’Ippolito. A scholar is included among the top collaborators of Anthony D’Ippolito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony D’Ippolito. Anthony D’Ippolito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Plasma epigenomic profiling to reveal molecular correlates of response and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer (mCRPC). 2025 ·Journal of Clinical Oncology ·Jacob E. Berchuck,Praful Ravi,Anthony D’Ippolito,Aparna Gorthi,(unknown),(unknown),(unknown),(unknown),Corrie Painter,Kristian Cibulskis,(unknown),Jenna I. Wurster,(unknown),(unknown),Mike Zhong,Kyle Gowen,Matthew L. Eaton,J. Carl Barrett,Heather A. Jacene	0
2	Cell-free circulating chromatin profiling for epigenomic characterization of mechanisms of response and resistance to sacituzumab govitecan in breast cancer. 2025 ·Journal of Clinical Oncology ·Ana C. Garrido-Castro,Aparna Gorthi,Se Eun Kim,Anthony D’Ippolito,Rita Nanda,Yara Abdou,Amy S. Clark,(unknown),(unknown),Natalie Sinclair,K. M. Steve Lo,(unknown),Nancy U. Lin,Harold J. Burstein,Elizabeth A. Mittendorf,Corrie Painter,Matthew L. Eaton,J. Carl Barrett,Nabihah Tayob,Sara M. Tolaney	0
3	Novel epigenomic liquid biopsy assay to predict estrogen receptor (ER) status and to infer ER pathway activation in breast cancer. 2024 ·Journal of Clinical Oncology ·Stefania Morganti,Jonathan A. Beagan,Anthony D’Ippolito,(unknown),Melissa E. Hughes,Juliann Chmielecki,Aparna Gorthi,Corrie Painter,J. Carl Barrett,Matthew L. Eaton,Matthew L. Freedman,Sara M. Tolaney,Nancy U. Lin,Heather A. Parsons	0
4	Erythroid lineage chromatin accessibility maps facilitate identification and validation of NFIX as a fetal hemoglobin repressor 2023 ·Communications Biology ·(unknown),Christopher Fiore,Brian Johnston,Anthony D’Ippolito,(unknown),John P. Carulli,Jeffrey R. Shearstone	5
5	14P Preclinical evaluation of intermittent dosing regimens on antitumor and PD activity of SY-5609, a potent and selective oral CDK7 inhibitor, in ovarian cancer xenografts 2021 ·Annals of Oncology ·Liv Johannessen,(unknown),(unknown),Nan Rosemary Ke,(unknown),Anthony D’Ippolito,Matthew L. Eaton,(unknown),Graham Hodgson	1
6	SY5609, a Potent and Selective CDK7 Inhibitor, Potentiates BTK Inhibitor Activity in Mantle Cell Lymphoma Preclinical Models 2021 ·Blood ·Liv Johannessen,(unknown),(unknown),Anthony D’Ippolito,Nan Rosemary Ke,(unknown),Matthew L. Eaton,(unknown),(unknown),Graeme Hodgson	1
7	518MO Tolerability and preliminary clinical activity of SY-5609, a highly potent and selective oral CDK7 inhibitor, in patients with advanced solid tumors 2021 ·Annals of Oncology ·Manish Sharma,Babar Bashir,Erika Hamilton,Dejan Juric,K. Papadopoulos,Debra L. Richardson,Geoffrey I. Shapiro,Graham Hodgson,Nan Rosemary Ke,Anthony D’Ippolito,(unknown),Li Zhu,(unknown),Hina Jolin,David A. Roth,Virginia M. Klimek,(unknown),Michael T. Kelly	6
8	Activity of SY-5609, an oral, noncovalent, potent, and selective CDK7 inhibitor, in preclinical models of colorectal cancer. 2020 ·Journal of Clinical Oncology ·Liv Johannessen,Nan Rosemary Ke,(unknown),(unknown),Anthony D’Ippolito,Shanhu Hu,Nisha Rajagopal,Matthew L. Eaton,Graeme Hodgson	3
9	Abstract C091: Preclinical evaluation of PK, PD, and antitumor activity of the oral, non-covalent, potent and highly selective CDK7 inhibitor, SY-5609, provides rationale for clinical development in multiple solid tumor indications 2019 ·Molecular Cancer Therapeutics ·Liv Johannessen,Shanhu Hu,Nan Rosemary Ke,Anthony D’Ippolito,Nisha Rajagopal,Jason Marineau,Anneli Savinainen,William C. Zamboni,Graeme Hodgson	9
10	Human genome-wide measurement of drug-responsive regulatory activity 2018 ·Nature Communications ·Graham D. Johnson,Alejandro Barrera,Ian C. McDowell,Anthony D’Ippolito,William H. Majoros,Christopher M. Vockley,Xingyan Wang,Andrew S. Allen,Timothy E. Reddy	29
11	Pre-established Chromatin Interactions Mediate the Genomic Response to Glucocorticoids 2018 ·Cell Systems ·Anthony D’Ippolito,Ian C. McDowell,Alejandro Barrera,Linda K. Hong,Sarah M. Leichter,Luke C. Bartelt,Christopher M. Vockley,William H. Majoros,Alexias Safi,Lingyun Song,Charles A. Gersbach,Gregory E. Crawford,Timothy E. Reddy	61
12	Glucocorticoid receptor recruits to enhancers and drives activation by motif-directed binding 2018 ·Genome Research ·Ian C. McDowell,Alejandro Barrera,Anthony D’Ippolito,Christopher M. Vockley,Linda K. Hong,Sarah M. Leichter,Luke C. Bartelt,William H. Majoros,Lingyun Song,Alexias Safi,D. Dewran Koçak,Charles A. Gersbach,Alexander J. Hartemink,Gregory E. Crawford,Barbara E. Engelhardt,Timothy E. Reddy	79
13	Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells 2016 ·Cell stem cell ·Joshua B. Black,Andrew F. Adler,Hong‐Gang Wang,Anthony D’Ippolito,(unknown),Timothy E. Reddy,Geoffrey S. Pitt,Kam W. Leong,Charles A. Gersbach	169
14	Direct GR Binding Sites Potentiate Clusters of TF Binding across the Human Genome 2016 ·Cell ·Christopher M. Vockley,Anthony D’Ippolito,Ian C. McDowell,William H. Majoros,Alexias Safi,Lingyun Song,Gregory E. Crawford,Timothy E. Reddy	123
15	Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancersbreakdown → 2015 ·Nature Biotechnology ·Isaac B. Hilton,Anthony D’Ippolito,Christopher M. Vockley,Pratiksha I. Thakore,Gregory E. Crawford,Timothy E. Reddy,Charles A. Gersbach	1343
16	Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elementsbreakdown → 2015 ·Nature Methods ·Pratiksha I. Thakore,Anthony D’Ippolito,Lingyun Song,Alexias Safi,(unknown),Ami M. Kabadi,Timothy E. Reddy,Gregory E. Crawford,Charles A. Gersbach	690
17	Glycogen synthase kinase-3 (Gsk-3) plays a fundamental role in maintaining DNA methylation at imprinted loci in mouse embryonic stem cells 2015 ·Molecular Biology of the Cell ·Gavin Meredith,Anthony D’Ippolito,(unknown),(unknown),(unknown),(unknown),(unknown),Anthony P. Popkie,Bradley W. Doble,George E. Marnellos,Christopher Adams,Yulei Wang,Christopher J. Phiel	6
18	485. Targeted Epigenome Editing by CRISPR/Cas9-Based Repressors for Silencing of Distal Regulatory Elements 2015 ·Molecular Therapy ·Pratiksha I. Thakore,Anthony D’Ippolito,Lingyun Song,Alexias Safi,(unknown),Ami M. Kabadi,Peggy J. Bledsoe,Timothy E. Reddy,Gregory E. Crawford,Charles A. Gersbach	0
19	Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci 2010 ·Journal of Biological Chemistry ·Anthony P. Popkie,(unknown),(unknown),Anthony D’Ippolito,Sigrid Eckardt,David Newsom,Joanna Groden,Bradley W. Doble,Bruce J. Aronow,K. John McLaughlin,Peter White,Christopher J. Phiel	68
20	Epidemiology of Pediatric Holiday-Related Injuries Presenting to US Emergency Departments 2010 ·PEDIATRICS ·Anthony D’Ippolito,Christy L. Collins,R. Dawn Comstock	30

About Anthony D’Ippolito

Anthony D’Ippolito is a scholar working on Aging, Cancer Research and Oncology, having authored 20 papers that have together received 2.6k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (5 papers), Genomics and Chromatin Dynamics (5 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Aging (170 citations), Business and International Management (162 citations) and Molecular Biology (2.3k citations). Anthony D’Ippolito has collaborated with scholars based in United States and Canada. Frequent co-authors include Timothy E. Reddy, Charles A. Gersbach, Gregory E. Crawford, Pratiksha I. Thakore, Christopher M. Vockley, Isaac B. Hilton, Lingyun Song, Alexias Safi, Ami M. Kabadi and William H. Majoros. Their work appears in journals such as Cell, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact